Background {#Sec1}
==========

Stroke causes five million deaths worldwide \[[@CR1], [@CR2]\] with escalating costs to the health system \[[@CR3]--[@CR6]\]. Most stroke cases (89 %) are admitted to hospital \[[@CR7]\], with approximately 50 % of sufferers left deceased or dependent \[[@CR8]\]. Thrombolysis using intravenous (IV) tissue plasminogen activator (tPA) is one of the few evidence-based acute stroke treatments \[[@CR9], [@CR10]\].

Despite the potential benefit offered by routine delivery of thrombolysis to eligible stroke patients, achieving and sustaining high rates of IV tPA delivery has been problematic.

While seeking treatment late is a major limiting factor on tPA delivery \[[@CR11], [@CR12]\], health system factors (i.e. circumstances that are determined by the health organisation or the health care provider rather than the individual) are important in improving access to thrombolysis for stroke patients. While there is no agreed benchmark for rates or levels of thrombolysis in practice, substantial change has been shown to be achievable such as an increase in tPA administration rate from 4.7 to 21.4 % of all stroke patients \[[@CR13]\].

The narrow treatment window of 4.5 h from stroke onset, negative impacts of inappropriate treatment, along with the multi-step, multi-disciplinary testing, and decision-making process needed to determine thrombolysis eligibility would indicate that complex interventions are required to change thrombolysis rates \[[@CR14]\]. Complex interventions are generally defined as those which involve a number of interacting components, require a number of behaviours or difficult behaviours, involve a number of groups or organisational levels and have a number of outcomes \[[@CR14]\], each of which is directly relevant to thrombolysis for acute stroke. Barriers to treatment include delays in stroke recognition by staff \[[@CR15]\], delays in obtaining and interpreting radiology imaging \[[@CR16]\], inefficiencies in emergency stroke care and delays in obtaining treatment consent \[[@CR17]\].

Study of the diffusion of new technologies indicates that while some innovations are largely adopted in less than 5 years \[[@CR18]\], others may fail to become commonplace due to barriers or failures at a higher level \[[@CR19]\]. In these contexts, the use of theoretical frameworks such as the Behaviour Change Wheel (BCW) \[[@CR20]\] can be helpful to clarify the range of factors which may need to be addressed in order to effect change. The BCW describes the three essential conditions for behaviour change to occur: capability, opportunity and motivation; nine intervention functions and seven policy categories are required for whole system change \[[@CR20]\]. Models and frameworks such as the BCW emphasise the importance of intervening not only at the level of the individual but also at an organisational or system level and at the broader policy level. While policy-level factors such as financial incentives may impact on thrombolysis over the long term \[[@CR21]\], in the short to medium term, health service providers may have the greatest potential impact by acting at a health system or organisational level.

A number of cross-sectional studies have described associations between higher stroke tPA rates and system-level factors such as hospital size and hospital type \[[@CR22], [@CR23]\] or characteristics such as staffing \[[@CR24]\] or stroke certification \[[@CR25]--[@CR28]\]. System-level approaches have been recommended to improve access to IV tPA and increase the proportion of patients receiving the treatment, including telemedicine and centralised hub and spoke models \[[@CR29]--[@CR31]\]. Some studies have described successful attempts to apply hospital pre-notification systems \[[@CR13]\] or quality-improvement approaches (e.g. analysing performance, with systematic efforts to improve it, ultimately resulting in better health outcomes) \[[@CR32], [@CR33]\], to increase tPA implementation for stroke.

However, system changes require substantial resources and engagement with quality improvement programmes. To our knowledge, there are no published reviews of a broad range of evidence-based health system factors associated with increased IV tPA administration rates for stroke.

Aims {#Sec2}
----

The aim of this study is to identify the following:Health system factors associated with higher rates of IV tPA administration for ischemic strokeThe effectiveness of system-focussed intervention strategies, which meet Cochrane Collaboration Evidence for Practice and Organization of Care (EPOC) study design guidelines, in improving IV tPA rates for treatment of ischemic stroke

Methods {#Sec3}
=======

Search strategy {#Sec4}
---------------

The literature review in MEDLINE, CINAHL, EMBASE and PsycINFO spanned from January 1997 to May 2014 and was performed as title, abstract and full-text review by three independent reviewers, with ambiguous articles discussed as a group to reach agreement. The search period was selected to align with the 1996 approval of the "clot-buster" drug \[[@CR34]\] and the release of the first tPA stroke guidelines \[[@CR35]\]. Search terms were confirmed in consultation with clinical stakeholders and a medical librarian. Available MeSH headings were used; otherwise, a "title" field search was conducted.

Limitations included published original research, English language, humans, adults, and used a combination of keyword searches of "tpa.m_titl" OR "rtpa.m_titl" OR "Tissue Plasminogen Activator OR Tissue Plasminogen Activator.m_titl" OR "Fibrinolytic Agents OR Fibrinolytic Agents.m_titl" OR "Recombinant Proteins OR Recombinant Proteins.m_titl" OR "Thrombolytic Therapy OR Thrombolytic Therapy.m_titl" AND "Stroke OR Stroke.m_title" OR "Brain Ischemia OR Brain Ischemia.m_titl" OR "Cerebral Hemorrhage or Cerebral Hemorrhage.m_titl".

Inclusion criteria {#Sec5}
------------------

The inclusion criteria are as follows:Studies that quantitatively assessed modifiable *health system factors* influencing rates of IV tPA for stroke; or*Intervention studies* aiming to improve rates of IV tPA administration for stroke

Exclusion criteria {#Sec6}
------------------

The exclusion criteria are as follows:Solely addressing patient characteristics such as age, race, education, income or clinical eligibility for thrombolysisNo denominator for calculating tPA rates or not reporting a tPA rateSolely assessing intra-arterial tPAAddressing only community-directed or patient-directed activities or changesHypothetical studies

Data extraction {#Sec7}
---------------

### Health system factors {#Sec8}

Using an extraction template, the following health system factors were extracted: sample characteristics, sample size, response rate, descriptors of setting, data collection method, rate and proportion of IV tPA administration, system factors addressed in relation to tPA delivery, factors affecting IV tPA rates, tPA criteria/guidelines and tPA time window. Using existing frameworks such as the BCW to categorise the identified health system factors was not successful as a number of the strategies could be categorised as having multiple intervention functions. Only three of the nine intervention functions and two of the seven policy functions described in the BCW were identified in the review. Therefore, a consensus process was used among the authors to identify practice-relevant categories under which to present the observational studies.

### Interventions {#Sec9}

Intervention studies were reviewed and categorised according to whether or not they met criteria for any of the four experimental designs defined and recommended by the EPOC design criteria. Data extracted were as follows: study design; setting; target group; study duration; intervention allocation; unit of analysis; allocation concealment; blinding; eligibility criteria; sample size; representativeness of sample; intervention conditions; outcome measures; statistical analysis; and findings.

Quality control {#Sec10}
---------------

Quality control involved second coding of a random sample of articles (10 %) at each review stage, i.e. initial extraction of studies and exclusion of ineligible studies (AR, SR, CP). Extracted data from all included studies were double-coded in full (AR, SR, CP, CK, JA, EK) and checked for agreement (AR). Agreement rates exceeded 90 % at all stages. All remaining differences in inclusions, exclusions and extracted data were discussed according to documented principles until consensus was reached, with subsequent re-coding completed wherever necessary.

Analysis {#Sec11}
--------

For the experimental studies, synthesis of the data involved meta-analysis where possible. Only studies which had pre- and post-test data specifying the rate of thrombolysis for intervention versus control groups were included in the meta-analysis. For the four study outcomes that were sufficiently similar, a pooled meta-analysis of outcomes was conducted using StatsDirect (version 2.7.9., Cheshire, UK). Heterogeneity was checked using *I* ^2^ and if high, random effects (DerSimonian-Laird method) pooling was used. Narrative synthesis was used to describe outcomes for the remainder of the experimental studies which could not be included in the meta-analysis due to heterogeneity of outcomes. Narrative synthesis \[[@CR36]\] involved verbal descriptions of the extracted data. For the observational studies, data synthesis involved tabulation of whether the study found a significant association with thrombolysis rate for any review-relevant factor followed by comparative narrative synthesis.

Results {#Sec12}
=======

The search resulted in 4323 citations (MEDLINE *n* = 1947, EMBASE *n* = 1760, PsycINFO *n* = 46, CINAHL *n* = 570). As indicated in Fig. [1](#Fig1){ref-type="fig"}, 34 studies reported associations between health system factors and IV tPA rates for ischemic stroke. Seven intervention studies that reported an improvement in IV tPA rates met the EPOC design criteria. Forty-seven intervention studies were excluded as being either pre-test-post-test designs with no control group or pilot tests with post-test only data. The types of intervention strategies studied in the 47 excluded publications included the following: the introduction of stroke units or "code-stroke" protocols; support for regional sites (e.g. hub and spoke models, telemedicine); changes in hospital protocols, staffing or rostering; and the "Get With The Guidelines" programme \[[@CR37]\].Fig. 1Inclusion and exclusion of citations

Health system factors {#Sec13}
---------------------

Table [1](#Tab1){ref-type="table"} summarises the 34 studies exploring associations between thrombolysis rates and health system factors. The majority (*n* = 19) of studies conducted multivariable analyses including both health system and patient factors. Health system factors were categorised post hoc and those with predominantly positive associations with tPA rates were as follows:Table 1Health system factors associated and not associated with higher thrombolysis ratesHealth system factorsStudies finding *no* association with higher thrombolysis rateStudies finding a *significant association* with higher thrombolysis rateTravel time and location (environmental restructuring)^a^ Shorter transport time or distance to hospital\[[@CR48]--[@CR51]\]\[[@CR52], [@CR53]\] Urban (vs rural)--\[[@CR54]--[@CR56]\] Centralised (hub model)--\[[@CR57]\]Training, skills and expertise (training and education)^a^ Treated by a neurologist--\[[@CR49], [@CR56]\], \[[@CR58]\] (no statistical test) Admitted to or treated in a neurology department or stroke unit\[[@CR59]\]\[[@CR60], [@CR61]\] Academic/teaching hospital\[[@CR56]\]\[[@CR55], [@CR60], [@CR62]--[@CR64]\], \[[@CR65]\]^b^ Continuing medical education/formal stroke training\[[@CR33], [@CR62]\]\[[@CR25]\] Higher volume of stroke admissions/number of neuro beds\[[@CR56], [@CR59]\]\[[@CR49], [@CR61], [@CR66]\] Accreditation as medical centre--\[[@CR49]\]Facilities and staffing (service provision)^a^ Emergency medical service or emergency department\[[@CR33]\]\[[@CR25]\] Neurologists, stroke nurse, stroke unit or team\[[@CR33]\]\[[@CR25], [@CR61], [@CR62], [@CR67]\] Neurological/neuroimaging services\[[@CR62]\]\[[@CR25], [@CR68]\] Laboratory services\[[@CR25], [@CR62]\]-- Larger/higher volume hospital\[[@CR56], [@CR61]\]\[[@CR69]\] Arrival during "on" hours\[[@CR57], [@CR70]\]-- Arrival on weekend\[[@CR70]\]\[[@CR49], [@CR71]\] 24 h or rapid CT/MRI\[[@CR62]\]-- Intensive care unit (cat 1)\[[@CR72]\]-- Stroke allocated beds\[[@CR33]\]--Organisational elements (guidelines and regulations)^a^ Commitment of medical organisation or stroke centre director\[[@CR25]\]\[[@CR62]\] Quality improvement outcomes or activities\[[@CR25], [@CR62]\]-- Pre-hospital notifications or triage tool\[[@CR73], [@CR74]\]\[[@CR75]\] Stroke-related certification\[[@CR76]\]\[[@CR77]\] Ambulance agreements/protocols or training\[[@CR33]\]\[[@CR33]\] (borderline positive association) Who interprets CT\[[@CR33]\]-- Stroke-specific protocols\[[@CR62]\] (acute stroke protocol)\[[@CR25], [@CR33], [@CR62]\] Transfer by a mobile emergency team or ambulance--\[[@CR48], [@CR50], [@CR78], [@CR79]\]^a^Terms in parentheses refer to BCW intervention functions and policy categories^b^Significant in univariate analysis only *Travel time and location*: e.g. urban rather than rural location, or a centralised/"hub" model linking outlying centres with other, generally larger, centres (environmental restructuring)*Training, skills and expertise*: treatment by neurologist or in a neurology department; admission to a stroke unit; treatment at academic/teaching hospital; treatment at a hospital with higher volume of stroke admissions or neurology beds; or accreditation as a "medical centre" (training and education)*Facilities and staffing*: having a neurologist, stroke nurse or stroke team; neurological or neuroimaging services; and weekend arrival (service provision)*Organisational elements*: use of stroke-specific protocols or transfer by ambulance/mobile emergency team rather than other means (guidelines and regulation)

The terms in parentheses refer to BCW intervention functions and policy categories.

Effectiveness of system-focussed interventions {#Sec14}
----------------------------------------------

Two intervention studies \[[@CR38], [@CR39]\] compared telemedicine with a telephone-only approach under the "hub and spoke" model. This group were too diverse in methodology and measurement to be included in a pooled analysis. Therefore, a narrative outcome description is provided. Neither of the telemedicine studies found a significant difference in IV tPA rates or patient outcomes, with one \[[@CR38]\] aiming to assess feasibility rather than effectiveness resulting in limited power to find any effect. Meyer et al. \[[@CR39]\] identified significantly higher rates of correct treatment decisions in telemedicine-treated patients compared to the telephone-only group. A third study \[[@CR40]\] explored a hub and spoke tele-consultation approach for one group of sites while a control group of sites proceeded with usual care. All sites found significant increases in IV tPA, while only tele-consultation sites significantly reduced mortality.

Four studies \[[@CR32], [@CR41]--[@CR43]\] explored approaches using quality improvement methods. Of these, two \[[@CR41], [@CR42]\] found a significant effect on IV tPA rates and patient outcomes based on modified Rankin scores. Scott et al. \[[@CR43]\] found a significant effect on IV tPA rates for some analyses, with no significant effect on service delivery measures or patient outcome. Schwamm et al. \[[@CR32]\] reported that involvement in the Get With The Guidelines Stroke programme was associated with an improvement over time in thrombolysis rates for patients arriving within 2 h of symptom onset.

The four quality improvement studies were included in pooled analysis of tPA rates. As the heterogeneity of the studies was high (*I* ^2^ = 98 % \[95 % CI = 97.1 to 98.5 %\]), a random-effects model was used, and the pooled estimate should be treated with caution. A borderline significant effect was found, with a pooled odds ratio of 2.1 (95 % CI = 1.0 to 4.5) and; *X* ^2^ = 3.783689, *df* = 1, *p* = 0.05. The seven intervention studies are described in Table [2](#Tab2){ref-type="table"}.Table 2Intervention studies meeting EPOC criteria for study design (*n* = 7)Citation, trial name, design, settingTarget group, study durationRandomization methodsEligibilitySample size, response rate, representativenessIntervention conditionsOutcome measuresStatistical analysisFindingsDemaerschalk 2010 \[[@CR38]\], USA\
STRokE DOC AZ\
RCT\
Regional (spoke) and Academic Metropolitan (hub) hospitalsHospital staff\
Dec. 2007--Oct. 2008Unit of analysis: patient\
Concealed allocation: yes\
Blinded: no\
Allocation to condition: permuted block randomization of patients stratified by sitePatient: \>18 years\
tPA window: onset \<3 h.Patient: *n* = 54\
Hospital: *n* = 3\
Response rate, 68.4 %.\
Representativeness: no demographic differences between groups\
Myocardial infarction higher in int. group (*p* \< 0.02).Int-1: audio and video contact with a certified stroke team at a hub site, who had access to medical history, performed NIHSS, and reviewed test results and CT images\
Int-2: a hub stroke consultant queried history, physical exam (including NIHSS), test results, CT reporttPA rate: denominator = acute stroke with \<3 h onset.\
Service delivery:\
1. Evaluation times (e.g. door-ED)\
2. Correct treatment decision\
Patient outcomes:\
1. Barthel Index (score 95--100)\
2. mRS (score ≤2).Cochran-Mantel-Haenszel test: comparison of correct decision rate between groups\
Fisher's exact test: rate of tPA, rate of intracranial haemorrhage, mortality, 90 day mRS\
Wilcoxon rank sum test: 90-day Barthel Index and time comparisonstPA rate: *Int-1*, 30 %; *Int-2*, 30 %\
Service delivery:\
1. NS\
2. NS\
Patient outcome:\
1. NS\
2. NS\
Note: insufficient power to assess difference in tPA rates between groups.Dirks, 2011 \[[@CR41]\], The Netherlands.\
PRACTISE\
Cluster RCT\
HospitalsHospital staff, including stroke neurologist and stroke nurse\
May 2005--Jan. 2008Unit of analysis: hospital\
Concealed allocation: no\
Blinded: no\
Allocation to condition: hospitals randomised after pairwise matching on hospital type, tPA rate, stroke patients/yearPatient: \>18 years\
Hospital: 100--500 stroke admissions/year\
tPA window: \<4 h of onsetPatient: *n* = 1657.\
Hospital: *n* = 12.\
Response rate: Not reported.\
Representativeness: *patients:* mean age, sex distribution and mean NIHSS at admission were similar between groupsInt: 5 × half day (across 2 years) meetings based on Breakthrough Series model. Teams of stroke neurologist and stroke nurse were created, who noted barriers to tPA use, set goals and plan actions\
C: usual practices.tPA rate: denominator = ischemic stroke, \<4 h onset\
Service delivery:\
1. Onset-to-door time (min)\
2. Door-to-needle time (min)\
Patient outcome:\
1. mRS \<3 (at 3 months)\
2. Quality of life---EuroQoL (at 3 months)\
3. MortalityIntention to treat\
Multilevel logistic and linear regressions: comparison of tPA use, mRS, QoL and mortality between intervention groups.\
Service delivery time analysis was adjusted for size, type and previous tPA rates, age, sex.tPA rate: *Int*, 44 %; *C*, 39 % (unadjusted OR = 1.24 \[1.02-1.51\]).\
Service delivery:\
1. NS\
2. NS\
Patient outcome:\
1. Poorer in C group\
2. NS\
3. NSMeyer 2008 \[[@CR39]\], USA\
STRokE DOC\
RCT\
Remote "spoke" hospitalsHospital staff\
Jan. 2004--Aug. 2007Unit of analysis: patient\
Concealed allocation: no\
Blinded: no\
Allocation to condition: patients randomised within permuted blocks stratified by sitePatient: \>18 years and ability to sign consent\
tPA window: \<3 h for treatment, but no time limit on eligibility for trialPatient: *n* = 222 (111 vs 111)\
Hospital: *n* = 4\
Response rate: *Patients:* Not reported.\
Representativeness: No demographic differences between groups. Int-1 had higher NIHSS score at presentation than Int-2 (*p* \< 0.005).Int-1: telemedicine (including video) consultation with patient by hub consultant including CT imaging\
Int-2: telephone consultations for spoke sites with hub consultants\
Hub provided treatment recommendations for both groupstPA rate: denominator = acute stroke.\
Service delivery:\
1. Correct treatment decisions\
2. Stroke onset to each point of care pathway (min)\
Patient outcome:\
1. Barthel Index (score 95--100).\
2. mRS (score ≤2).Fisher's exact test: difference in tPA rate, functional outcomestPA rate: *Int-1,* 28 %; *Int-2*, 23 % (OR = 1.3 \[0.7--2.5\], *p* = NS).\
Service delivery:\
1. Greater in Int-1 compared to Int-2 (98 vs 82 %, OR = 10.9 \[2.7--44.6\], *p* \< 0.001).\
2. Few differences in service delivery times.\
Patient outcome:\
1. No difference between groups\
2. No difference between groupsMorgenstern et al. 2003 \[[@CR42]\], USA\
TTL Temple Foundation Stroke Project\
CBA\
Hospitals in two communitiesCommunity members and hospital staff\
Feb. 1998--Sept. 2000Unit of analysis: patient\
Concealed allocation: no\
Blinded: no\
Allocation to condition: comparison community selected to match chosen intervention communityPatient: \>21 years and county resident\
tPA window:\<3 hPatient:\
*Phase 1: n* = 277 (136 vs 141)\
*Phase 2: n* = 499 (266 vs 233)\
*Phase 3*: *n* = 150 (80 vs 70)\
Hospital: *n* = 10\
Response rate: *Patients:* N/A\
*Hospitals:* not reported\
Representativeness: hospital characteristics reportedInt: community mass media, hospital-based systems change via multi-disciplinary team development of ED protocols, problem solving, medical education, feedback.\
C: not specified.tPA rate: denominator = ischemic stroke\
Service delivery:\
1. Delay time to hospital\
2. Staff-reported barriers to treatment\
Patient outcome: none assessedFisher's exact test: rate of tPA\
ANOVA: delay in timestPA rate: *Int (phases 1--3)*: 2.2, 8.6, 11.2 % (*p* \< 0.007); *C (phases 1--3):* 0.7, 0.9 %, (*p* = NS)\
Service delivery:\
1. No difference in either group\
2. Reduction for Int group only (no statistical test)Schwamm et al. 2009 \[[@CR32]\], USA\
ITS\
Academic and community hospitalsHospitals\
April 2003-July 2007Unit of analysis: hospital\
Concealed allocation: N/A\
Blinded: N/A\
Allocation to condition: N/A (ITS design)Patient: Principal diagnosis of stroke or TIA, arrival \<2 h from onset, ICD-9. Retrospective chart review to confirm stroke/TIA\
Hospital: \>30 patientsPatient: *n* = 322,847 (ischemic = 73.2 %; TIA = 26.8 %)\
Hospital: *n* = 790\
Response rate: Unclear. Staggered recruitment over 4 years. By Jan. 2007, 8.35 % hospitals had dropped out (*n* = 66)\
Representativeness: hospital characteristics providedInt: quality improvement (Get With The Guidelines \[GWTG\]) programme, with organisational meetings, tool kits, collaborative workshops, hospital recognition, decision support information, performance feedback.tPA rate: denominator = stroke or TIA, and arrival \<2 h of onset\
Service delivery: none assessed\
Patient outcome:\
1. Symptomatic intracranial haemorrhage within 36 h of tPACochran-Mantel-Haenszel test: mean score for changes in rate of tPA and intracranial haemorrhage over timetPA rate: significant increase from baseline (42.1 %) to year 5 (72.8 %; *p* \< 0.0001).\
Patient outcome:\
1. NS over time\
Greatest improvement (composite performance/program year in GWTG) in hospitals with more beds (*p* \< 0.0001), larger annual stroke volume (*p* \< 0.0001) and teaching status (*p* \< 0.0001)Scott et al. 2013 \[[@CR43]\], USA\
INSTINCT\
Cluster RCT\
Community hospitalsPhysicians, pharmacists, nurses, EMS, admin teams\
Jan.--Dec. 2007Unit of analysis: hospital\
Concealed allocation: no\
Blinded: no\
Allocation to condition: within pairs, hospitals were randomised to intervention or control groups. Randomisation reversed for three pairs to achieve greater urban/rural balanceHospitals: discharging ≥100 stroke patient/year, \<100 000 ED visits/year and non-academic stroke centres\
tPA window: not specifiedHospitals: *n* = 24\
Response rate: 83 %\
Representativeness: not reportedInt: clinical practice guideline promotion, development of local stroke champions, continuing education, telephone support for treatment decision, academic detailing, audit and feedback\
C: usual practicestPA rate: denominator = ischemic stroke\
Service delivery:\
1. Adherence to tPA guidelines\
Patient outcome:\
1. Safety data from proportion of patients (2.2 %), with reported haemorrhageIntention-to-treat (ITT) and target population (without one pair that was excluded after randomisation)\
Generalised linear mixed model: assumed intra-hospital correlation between tPA rates at pre- and post- intervention periodstPA rate: *ITT:* Int (pre and post), 1.25 and 2.79 %; C (*n* = 1; pre and post), 1.25 and 2.10 %. Int vs C, *p* = NS.\
*Target analysis:* Int (pre and post), 1.0 and 2.62 %; C (pre and post),1.09 and 1.72 %. Int vs C, RR = 1.68 \[1.09--2.57\], *p* = 0.02\
Service delivery:\
1. NS difference between groups\
Patient outcome:\
1. NS difference between groupsTheiss et al. 2013 \[[@CR40]\], Germany\
CBA\
Comprehensive stroke centres, and primary care hospitalsHospitals\
2006--2009Unit of analysis: hospital\
Concealed allocation: no\
Blinded: not reported\
Allocation to condition: hospitals matched on beds, distance from closest hub site and departments of internal medicineHospitals: not reported\
No study hospitals had specialised stroke care prior to study startHospitals: *n* = 15\
Response rate: not reported.\
Representativeness: not reportedInt: tele-consultation service. Consisted of hub (*n* = 5) and spoke (*n* = 5) sites\
C: usual practicestPA rate denominator: all stroke\
Service delivery: none assessed\
Patient outcome:\
1. Intracerebral haemorrhage\
2. MortalityMean and SEM: for descriptive data\
Student *t* and Fisher exact tests: longitudinal and pairwise comparisons, pooled ischemic stroke mortalitytPA rate: *Hub sites*: (pooled) increased 4.2 to 7.7 % (*p* \< 0.0001); *Spoke sites:* (pooled) increased 1.1 to 5.9 % (*p* \< 0.0001); *C:* (one hospital only) increased 0.8 to 5.7 % (*p* = 0 . 03).\
Patient outcome:\
1. NS\
2. Significant decreases in spoke site only (10.3 to 7.3 %, *p* = 0.03)*Abbreviations: C* control group, *CBA* controlled before and after trial, *CT* computer tomography, *ED* emergency department, *EMS* emergency medical service, *RCT* randomised controlled trial, *Int* intervention group, *ITS* interrupted time series, *mRS* modified Rankin score, *NIHSS* National institute of Health Stroke Scale, *TIA* transient ischemic attack, *tPA* tissue plasminogen activator, *QoL* quality of life, *N/A* not applicable

Discussion {#Sec15}
==========

This systematic review brings together the empirical evidence regarding potential strategies for improving thrombolysis rates for acute stroke. The review data provide a basis on which stroke service providers can identify which strategies are more likely to be good investments for increasing rates of thrombolysis. As per the literature regarding complex interventions \[[@CR14]\] and frameworks such as the BCW \[[@CR20]\], a range of strategies or factors are related to achieving change in thrombolysis rates. Of note is that the literature only addresses three of the nine intervention functions and two of the seven policy categories raised in the BCW framework, suggesting a much wider range of strategies could be tested in the future.

A small number of system-related factors are associated with higher rates of IV tPA administration for ischemic stroke. Systems-change interventions, based on multi-component quality improvement approaches, can increase the proportion of eligible stroke patients receiving IV tPA.

The observational literature regarding factors associated with higher stroke tPA rates was heterogeneous in methodology and types of factors assessed, but it is unclear whether each study had sufficient power to detect an association for each factor. The literature indicates that health systems should aim to ensure that most stroke patients are treated in a way that minimises access disadvantages for rural populations; maximises access to neurological and stroke-specific expertise and experience; ensures stroke units are widely available; and implements stroke-specific protocols. The association of higher IV tPA rates with treatment at a teaching hospital or a hospital with larger stroke or IV tPA treatment volume suggests that expertise and experience within such settings is key to increased IV tPA rates. The mixed findings regarding the importance of treatment at a larger hospital and arrival during "on" hours or weekends indicate that greater size and availability of staff alone do not produce higher IV tPA rates. However, it must be noted that observational studies cannot be used to draw definitive conclusions regarding causation. The observational studies were also largely retrospective in design and had limited capacity to identify and assess confounding factors. Therefore, a greater focus must be directed towards the data from the experimental or intervention studies.

Organisational elements such as stroke certification and quality improvement activities were not associated with higher IV tPA rates. One study \[[@CR25]\] failed to find an association between facilities, staffing and organisational elements and quality improvement outcomes or activities. These elements are often the focus of system-change interventions and can be resource intensive to implement. Therefore, robust experimental studies are essential to providing clarity about cost-effective approaches to improved IV tPA rates. Organisational elements such as stroke-related certification or time on the Get With The Guidelines programme did not increase IV tPA rates.

The intervention studies suggest that while quality-improvement or system-change interventions can be effective in increasing IV tPA rates, studies are heterogeneous and effects may be small or inconsistent. The PRACTISE trial \[[@CR41]\] found a positive effect on IV tPA rates and patient functioning following a Breakthrough Series intervention. The INSTINCT trial \[[@CR43]\] reported a positive effect only when the analysis focussed on a subset of study sites. The INSTINCT intervention placed less emphasis on collaborative meetings compared to the PRACTISE trial but included stroke champions, education/support for treatment decision making and performance feedback \[[@CR43]\]. The Morgenstern et al. study \[[@CR42]\] identified a greater increase in IV tPA rates in intervention sites, compared to control sites.

This study \[[@CR42]\] differed from the two other studies by including community-focussed mass media. It also included hospital-based change via multi-disciplinary teams, development of emergency department protocols, problem solving, medical education and performance feedback. Given the small number of hospitals involved, the choice of patient rather than hospital as the unit of analysis, and the lack of any head-to-head analysis across groups, some caution should be applied to interpreting the results of the Morgenstern et al. study \[[@CR42]\].

Other studies support the finding that quality improvement strategies can provide modest positive effects on other aspects of stroke care \[[@CR32], [@CR44], [@CR45]\]. The "Stroke 90:10" trial found an 11 % relative improvement in some aspects of initial assessment and care for stroke patients following collaborative quality improvement \[[@CR45]\]. Another study involving workshops, education, site-based teams, performance feedback and decisional support suggests that improvements in thrombolysis occurred over time \[[@CR32]\]. While the study could be classified as an interrupted time series based on quarterly measurements over 4 years, the analysis did not follow usual approaches to analysing time-series data. Although the cost of IV tPA administration was not addressed in the reviewed studies, the scope of multi-component, multi-site interventions suggests the resources required are substantial.

Two studies \[[@CR38], [@CR39]\] compared telemedicine with a telephone-only approach, focusing on environmental restructuring rather than quality improvement to increase IV tPA delivery. Conclusions are difficult to make, as neither study indicated sufficient power to detect a difference in IV tPA rates. The study of tele-consultation compared to usual care \[[@CR40]\] suggested, but did not conclusively demonstrate, patient outcome benefits, given a failure to statistically examine experimental versus control site outcomes. A later pooled analysis confirmed telemedicine consultations were not associated with increased thrombolysis rates \[[@CR46]\]. While these changes may increase access to expert care, they lack robust evidence.

Observational and intervention data suggest that optimising IV tPA administration requires availability of expertise and protocols. Intervention studies suggest more in-depth reporting of the degree to which various intervention strategies may assist in understanding the best way forward. While multi-component approaches appear promising, two important questions emerge:Could a comprehensive intervention approach, encompassing the range of strategies represented in the reviewed studies, achieve a more substantial increase in IV tPA rates than that found to date? If so, what is the cost-benefit?Could a more streamlined quality improvement approach be identified, using a subset of elements? This may require comprehensive and systematic approaches to study the implementation of prior and future multi-component interventions, followed by trials using a subset of "best-bet" strategies.

The broader context is also important to consider, such as the financial incentives to hospitals for or against thrombolysis delivery in certain settings \[[@CR21]\]. Adapting system thinking where components of the health system are dynamic and interlinked may assist in further understanding the network of relations and feedback loops impacting on the uptake of new innovations \[[@CR47]\]. It may also be useful to develop a broader theoretical framework that could be applied to future studies in this area.

Limitations should be considered when interpreting the study tables: firstly, the reported rates of IV tPA (see Table [2](#Tab2){ref-type="table"}) are dependent on denominator and eligibility criteria, which can affect the power of the study to detect a difference in the outcome; secondly, the variability in factors explored across studies of descriptive health system factors limits the ability to make comparisons among studies; and finally, the nature of changing care at a system level limits design rigour such as the ability to blind sites to group allocation. As a "Google" search was not used, a small number of unpublished studies may not have been identified.

Conclusion {#Sec16}
==========

Access to teaching hospitals and hospitals with larger stroke and IV tPA treatment volumes is associated with increased IV tPA administration rates for stroke, although results should be viewed against variability in eligibility criteria and type of denominator used. Interventions aiming to increase rates of IV tPA are resource intensive and comparisons between studies are difficult due to insufficient power and limitations in study analysis. More empirical data regarding the effects of efforts to improve access to thrombolysis for those living long distances (e.g. mobile thrombolysis) from a tPA-capable hospital and 24-h availability of expertise in acute stroke care are required, as is more thoughtfully designed and well-reported trials of quality improvement interventions.
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